These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9707766)

  • 41. Is new visual prostate symptom score useful as International Prostate Symptom Score in the evaluation of men with lower urinary tract symptoms? A prospective comparison of 2 symptom scores in Turkish society.
    Ceylan Y; Gunlusoy B; Degirmenci T; Kozacioglu Z; Bolat D; Minareci S
    Urology; 2015 Mar; 85(3):653-7. PubMed ID: 25733282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).
    Coyne KS; Barsdorf AI; Thompson C; Ireland A; Milsom I; Chapple C; Kopp ZS; Bavendam T
    Neurourol Urodyn; 2012 Apr; 31(4):448-54. PubMed ID: 22396308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH; Kwon H; Park YW
    Urology; 2013 Nov; 82(5):1008-12. PubMed ID: 24041675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.
    Chapple CR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernández Fernández E;
    Eur Urol; 2011 Mar; 59(3):342-52. PubMed ID: 21109344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. "Alphabet soup" and the prostate: LUTS, BPH, BPE, and BOO.
    Silverman WM
    J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S1-4. PubMed ID: 15038396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevalence of lower urinary tract symptoms in men and its influence on their quality of life: Boxmeer Study].
    Sonke GS; Kolman D; de la Rosette JJ; Donkers LH; Boyle P; Kiemeney LA
    Ned Tijdschr Geneeskd; 2000 Dec; 144(53):2558-63. PubMed ID: 11191793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Questionnaire analysis on sex difference in lower urinary tract symptoms.
    Kakizaki H; Matsuura S; Mitsui T; Ameda K; Tanaka H; Koyanagi T
    Urology; 2002 Jan; 59(1):58-62. PubMed ID: 11796282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.
    Ezz el Din K; Kiemeney LA; de Wildt MJ; Debruyne FM; de la Rosette JJ
    Urology; 1996 Sep; 48(3):393-7. PubMed ID: 8804492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
    Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology Research" (PETER) study group.
    Weibl P; Laurinc P; Tomaškin R; Klatte T; Shariat F S; Helbich M; Fačkovcova D; Bujdák P
    Wien Klin Wochenschr; 2015 Jun; 127(11-12):434-9. PubMed ID: 25821056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective comparison of the novel visual prostate symptom score (VPSS) versus the international prostate symptom score (IPSS), and assessment of patient pain perception with regard to transrectal ultrasound guided prostate biopsy.
    Els M; Heyns C; van der Merwe A; Zarrabi A
    Int Braz J Urol; 2019; 45(1):137-144. PubMed ID: 30620160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy.
    Apolone G; Cattaneo A; Colombo P; La Vecchia C; Cavazzuti L; Bamfi F
    Eur J Cancer Prev; 2002 Oct; 11(5):473-9. PubMed ID: 12394245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lower urinary tract symptoms: social influence is more important than symptoms in seeking medical care.
    Wolters R; Wensing M; van Weel C; van der Wilt GJ; Grol RP
    BJU Int; 2002 Nov; 90(7):655-61. PubMed ID: 12410742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the effectiveness of IPSS and VPSS without any help in LUTS patients: a prospective study.
    Guzelsoy M; Aydos MM; Coban S; Turkoglu AR; Acibucu K; Demirci H
    Aging Male; 2018 Sep; 21(3):193-199. PubMed ID: 29228847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Assessment of reproducibility and unidimensionality of International Prostate Symptom Score Japanese version].
    Yoshimura A; Niimi M; Akaza H; Takeshima H; Otani M; Noguchi R; Ishikawa S; Ohashi Y
    Nihon Hinyokika Gakkai Zasshi; 1997 Dec; 88(12):1013-20. PubMed ID: 9465601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Latin American study on patient acceptance of the International Prostate Symptom Score (IPSS) in the evaluation of symptomatic benign prostatic hyperplasia.
    Rodrigues Netto N; de Lima ML; de Andrade EF; Apuzzo F; da Silva MB; Davidzon IM; Moises MJ; Chamma EJ; Bogado H
    Urology; 1997 Jan; 49(1):46-9. PubMed ID: 9000184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of an educational multimedia prostate program on the International Prostate Symptom Score.
    van Schaik P; Ahmed T; Suvakovic N; Hindmarsh JR
    Eur Urol; 1999; 36(1):36-9. PubMed ID: 10364653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Age and gender stratified normative values for the International Prostate Symptom Score for adults aged 60 years and over.
    Booth L; Skelton DA; Hagen S; Booth J
    Neurourol Urodyn; 2018 Nov; 37(8):2732-2739. PubMed ID: 29926963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The burden of prostatic calculi is more important than the presence.
    Park B; Choo SH
    Asian J Androl; 2017; 19(4):482-485. PubMed ID: 27184549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation and reliability of a smartphone application for the International Prostate Symptom Score questionnaire: a randomized repeated measures crossover study.
    Kim JH; Kwon SS; Shim SR; Sun HY; Ko YM; Chun DI; Yang WJ; Song YS
    J Med Internet Res; 2014 Feb; 16(2):e38. PubMed ID: 24513507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.